Drug
HRS-9813 clinical trials
Also written HRS-9813.
- studies test it
- 5
- open now
- 1
- in phase 3
- 0
- first study started
- 2024
Keep track of what changes. Save the HRS-9813 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
5 studies that test it; most in 2025 (3)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses HRS-9813 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary FibrosisRecruitingPhase 2Guangdong Hengrui Pharmaceutical Co., LtdNCT07192939Written as HRS-9813 capsules
- Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy SubjectsCompletedPhase 1Guangdong Hengrui Pharmaceutical Co., LtdNCT07229716Written as HRS-9813 Capsule
- A Trial of HRS-9813 in Healthy SubjectsCompletedPhase 1Guangdong Hengrui Pharmaceutical Co., LtdNCT06821464Written as HRS-9813
- A Trial of HRS-9813 Capsule and Tablet in Healthy SubjectsCompletedPhase 1Guangdong Hengrui Pharmaceutical Co., LtdNCT06939504Written as HRS-9813 Capsule
- A Trial of HRS-9813 in Healthy VolunteersCompletedPhase 1Guangdong Hengrui Pharmaceutical Co., LtdNCT06514963Written as HRS-9813